NUMD
Nu-Med Plus, Inc. [NUMD] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NUMD Stock Summary
Top 10 Correlated Stocks
NUMD
In the News
NUMD Financial details
Company Rating
-
Market Cap
4.07M
Income
-127.99K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-90.93
Forward P/E
-
PEG
8.190246282336E+16
P/S
-
P/B
-19.84
P/C
-
P/FCF
-30.25
Quick Ratio
0.08
Current Ratio
0.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-6.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
250%
-
-
-
-
SMA20
-25%
SMA50
500%
SMA100
200%
Inst Own
-
Inst Trans
-
ROA
-209%
ROE
29%
ROC
0.54%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.009-0.09
52W High
-
52W Low
-
RSI
46.69
Rel Volume
0.9
Avg Volume
41.26K
Volume
37K
Perf Week
-20.89%
Perf Month
581.18%
Perf Quarter
216.46%
Perf Half Y
28.19%
-
-
-
-
Beta
0.965
-
-
Volatility
0.01%, 0.02%
Prev Close
-6.29%
Price
0.05538
Change
-3.85%
Company Profile
- Volume Average 41.26K
- Market Capitalization 4.07M
- Employee 2
- CEO Mr. William Charles Hayde
- Headquarters Salt Lake City,UT,US
- IPO Date 2014-09-25
-
Website
https://www.nu-medplus.com 
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
